USANA Health Sciences, Inc. USNA
14.50
0.24
1.68%
as of 25 Sep
- Market cap
- $263.5M
- P/E
- 0.0×
Follow USNA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
| ROE |
+8 more TTM periods Free account |
3.20% | 2.02% | 1.65% | (4.19%) |
| ROA | 2.43% | 1.44% | 1.19% | (3.08%) | |
| ROIC | 6.83% | 6.24% | 5.85% | (0.19%) | |
| Return on Tangible Assets | 7.03% | 4.23% | 3.27% | (8.22%) | |
| Average Days of Receivables | 0.00 | 1.69 | 3.81 | 1.33 | |
| Free Cash Flow per Share | 1.02 | 0.67 | 0.38 | 1.08 | |
| Free Cash Flow | 18.69 | 12.43 | 6.91 | 19.90 | |
| Capital Expenditures | (12.83) | (9.92) | (9.71) | (7.82) | |
| Piotroski F-Score | 3.00 | 5.00 | 4.00 | 3.00 | |
| Other line items | |||||
| Cash ROIC | 4.68% | 3.23% | 2.35% | 3.99% | |
| Accounts Receivable Turnover | 0.00 | 141.83 | 108.44 | 173.97 | |
| Accounts Payable Turnover | 16.34 | 13.73 | 13.76 | 12.36 | |
| Inventory Turnover | 2.46 | 2.33 | 2.45 | 2.43 | |
| Average Days of Payables | 31.16 | 31.37 | 28.50 | 27.34 | |
| Days of Inventory on Hand | 174.40 | 186.47 | 169.22 | 152.99 | |
| Tax Rate | (0.63) | (0.72) | (0.77) | (12.53) | |
| Research and Development Expense of Revenue | 0.00% | 0.00% | 0.00% | 0.00% | |
| Selling, General and Administrative Expense of Revenue | 74.60% | 73.49% | 72.95% | 73.61% | |
| Share Based Compensation of Revenue | 1.50% | 1.49% | 1.56% | 1.55% | |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating CF/Net income | 1.86 | 2.08 | 1.87 | (1.25) | |
| Depreciation/Fixed assets | 0.37 | 0.42 | 0.41 | 0.72 | |
| Capex/Depreciation | (0.36) | (0.25) | (0.25) | (0.12) | |
| Revenue per Share | 49.89 | 49.92 | 50.33 | 49.41 | |
| Operating CF per Share | 1.72 | 1.21 | 0.90 | 1.50 | |
| Capex per Share | (0.70) | (0.54) | (0.53) | (0.42) | |
| Capex to Sales | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net Profit Margin | 1.86% | 1.16% | 0.96% | (2.43%) |
Columns are period end dates